Allergan to buy Zeltiq for about US$2.48B

Allergan early Monday announced just the latest in a series of big acquisitions

Zeltiq Aesthetics Inc opened for trading at $47.01 and hit $51.97 on the upside on Friday, eventually ending the session at $49.4, with a gain of 4.93% or 2.32 points. Current stock price is in the upbeat territory taking into account of 20 days moving average with 2.20% and continued bullish run for 50 days moving average with 4.91%.

Zeltiq's shares jumped 12.6 per cent to US$55.65 in premarket trading on Monday.

Botox maker Allergan is spending about $2.48 billion to buy Zeltiq Aesthetics Inc. and its CoolSculpting system for reducing fat. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Shares of ZELTIQ Aesthetics (NASDAQ:ZLTQ) opened at 56.06 on Tuesday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the company. The most optimistic analyst sees the stock reaching $58.00 while the most conventional predicts the target price at $45.00. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 33.3%.

Leerink Swann restated their market perform rating on shares of ZELTIQ Aesthetics, Inc.

Zeltiq reported about $95 million in revenue for the third quarter, up from $61 million year-over-year, according to filings. Bearish revenue estimates established at $102M while the bullish revenue forecast has been figured out at $103.83M.

In other ZELTIQ Aesthetics news, insider Keith J. Sullivan sold 8,000 shares of the firm's stock in a transaction on Monday, December 5th. OVERWEIGHT signal was given by 0 and Underweight signal was issued by0 Analyst.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance.

Harwood Feffer LLP ( is investigating potential claims against the board of directors of ZELTIQ Aesthetics, Inc.

The 52-week high of the share price is -1.36% and 52-week low of the share price is 46.85%. The company's revenue was up 55.6% compared to the same quarter a year ago. The company had Year Ago Sales of 78.22 Million.

While taking a glance at financials, we can look at a number of key indicators.

RBC Bearings Incorporated (NASDAQ:ROLL) traded 105168 shares and its share price moved down -0.04% to close at $96.37. ZELTIQ Aesthetics had a negative return on equity of 6.45% and a net margin of 9.48%. Frontier Communications Corporation (NASDAQ:FTR), at its latest closing price of $3.28, it has a price-to-book ratio of 0.82, compared to an industry average at 5.15.



Latest news

Oklahoma Lawmaker Wants Men To Approve Abortion, Calls Women 'Hosts'
The legislation would require a woman seeking an abortion first to obtain written permission from her sexual partner. For the record, Oklahoma is second only to Louisiana when it comes to restrictions on abortion.

Merkel presses Tunisian PM on asylum solution
It was largely a delay in getting the right documents, including identity papers, that prevented Amri from being repatriated. Until now, the north african country has rejected attempts to set up asylum centres there to ease the burden on Europe.

Adele crowned queen of pop with Grammy clean sweep
I thank God for my family, my wonderful husband, my handsome daughter, my fans for bringing me so much happiness and support. Her comments have sparked a huge backlash on social media, with many taking to Twitter to criticise the mother-of-one.

Ex-Bengal Marquand Manuel is Falcons' new defensive coordinator
Manuel aided in the development of rookie safety Keanu Neal and second-year cornerback Jalen Collins into major contributors. Smith could stay with the Falcons in an advisory role, Rapoport reported.

Other news